Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 728 million compared to CNY 693.05 million a year ago. Revenue was CNY 728.49 million compared to CNY 693.73 million a year ago.

Net income was CNY 10.78 million compared to CNY 7.53 million a year ago. Basic earnings per share from continuing operations was CNY 0.0112 compared to CNY 0.0078 a year ago. Diluted earnings per share from continuing operations was CNY 0.0112 compared to CNY 0.0078 a year ago.